Ignite Creation Date:
2024-05-06 @ 6:28 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05675462
Status:
RECRUITING
Last Update Posted:
2023-03-06
First Post:
2022-12-29
Brief Title:
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Organization:
Fudan University